NATIONAL HEALTHCARE CORP

NHC

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Driehaus Capital Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 5,099,324Value: $116.5M

# Signal Note: Driehaus Capital Entry into NHC Driehaus Capital's $116.5M initiation in National Healthcare Corp (NHC) signals conviction in the senior housing/skilled nursing operator facing potential near-term catalysts from labor normalization and operational leverage recovery post-pandemic. The timing aligns with improving Medicare reimbursement dynamics and stabilizing occupancy trends in the sector, though this is a healthcare services play rather than a biotech asset and warrants monitoring for any underlying M&A or strategic repositioning thesis driving the growth-focused manager's entry.

Deerfield ManagementNEW

More NHC Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

TNDM2 funds NUVL2 funds VEEV2 funds VCYT2 funds PODD2 funds NBIX2 funds BBNX2 funds TMDX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

**Signal Note: Deerfield initiates NHC position** Deerfield's $1.9M entry into National Healthcare Corp—a nursing home and assisted living operator—likely reflects conviction in long-term care facility consolidation tailwinds and improved operational leverage post-pandemic. The timing suggests confidence in NHC's ability to capitalize on labor market stabilization and pricing power in a fragmented sector facing structural demand from aging demographics.